Tlr7 drives sex differences in age- and Alzheimer's disease-related demyelination.

TitleTlr7 drives sex differences in age- and Alzheimer's disease-related demyelination.
Publication TypeJournal Article
Year of Publication2024
AuthorsLopez-Lee C, Kodama L, Fan L, Zhu D, Zhu J, Wong MYing, Ye P, Norman K, Foxe NR, Ijaz L, Yu F, Chen H, Carling GK, Torres ER, Kim RD, Dubal DB, Liddelow SA, Sinha SC, Luo W, Gan L
JournalScience
Volume386
Issue6725
Paginationeadk7844
Date Published2024 Nov 29
ISSN1095-9203
KeywordsAging, Alzheimer Disease, Animals, Apolipoprotein E4, Demyelinating Diseases, Disease Models, Animal, Female, Genes, X-Linked, Humans, Interferon Type I, Male, Membrane Glycoproteins, Mice, Mice, Inbred C57BL, Microglia, Myelin Sheath, Oligodendroglia, Sex Characteristics, Sex Chromosomes, tau Proteins, Toll-Like Receptor 7
Abstract

Alzheimer's disease (AD) and other age-related disorders associated with demyelination exhibit sex differences. In this work, we used single-nuclei transcriptomics to dissect the contributions of sex chromosomes and gonads in demyelination and AD. In a mouse model of demyelination, we identified the roles of sex chromosomes and gonads in modifying microglia and oligodendrocyte responses before and after myelin loss. In an AD-related mouse model expressing APOE4, XY sex chromosomes heightened interferon (IFN) response and tau-induced demyelination. The X-linked gene, Toll-like receptor 7 (Tlr7), regulated sex-specific IFN response to myelin. Deletion of Tlr7 dampened sex differences while protecting against demyelination. Administering TLR7 inhibitor mitigated tau-induced motor impairment and demyelination in male mice, indicating that Tlr7 plays a role in the male-biased type I Interferon IFN response in aging- and AD-related demyelination.

DOI10.1126/science.adk7844
Alternate JournalScience
PubMed ID39607927